12 unchanged sentences
Our Director since February 2018.
−Removed: William Carapezzi 64 Executive Vice President, Global Business Services and Transformation since June 2020.
−Removed: Senior Vice President of Global Business Operations from June 2013 until June 2020.
−Removed: Senior Vice President of Global Tax from 2008 until June 2013.
−Removed: D’Amelio 64 Chief Financial Officer, Executive Vice President since January 2022.
−Removed: Chief Financial Officer and Executive Vice President, Global Supply from June 2020 until December 2021.
−Removed: Chief Financial Officer, Executive Vice President, Business Operations and Global Supply from November 2018 until June 2020.
−Removed: Executive Vice President, Business Operations and Chief Financial Officer from December 2010 until October 2018.
−Removed: Senior Vice President and Chief Financial Officer from September 2007 until December 2010.
−Removed: Director of Zoetis Inc.
−Removed: and Humana Inc.
−Removed: and Chair of the Humana Inc.
−Removed: Board of Directors’ Audit Committee.
−Removed: Mikael Dolsten 63 Chief Scientific Officer, President, Worldwide Research, Development and Medical since January 2019.
+Added: Denton 57 Chief Financial Officer, Executive Vice President since May 2022.
+Added: Executive Vice President, Chief Financial Officer, Lowe’s Companies, Inc., from November 2018 until April 2022;
+Added: Executive Vice President and Chief Financial Officer, CVS Health Corporation (a diversified health solutions company), from January 2010 until November 2018.
+Added: Director of Tapestry, Inc.
+Added: Effective March 1, 2023, Director of Haleon plc.
+Added: 2022 Form 10-K 23
+Added: Name Age Position
+Added: Mikael Dolsten 64 Chief Scientific Officer and President, Worldwide Research, Development and Medical since January 2019.
President of Worldwide Research and Development from December 2010 until December 2018.
4 unchanged sentences
Director of Agilent Technologies, Inc, and Vimian Group AB.
−Removed: 2021 Form 10-K 23
−Removed: Name Age Position
+Added: Director of Karyopharm Therapeutics Inc.
+Added: from 2015 to 2021.
Lidia Fonseca 54 Chief Digital and Technology Officer, Executive Vice President since January 2019.
2 unchanged sentences
Director of Tegna, Inc.
−Removed: Angela Hwang 56 Group President, Pfizer Biopharmaceuticals Group since January 2019.
+Added: and Medtronic plc.
+Added: Angela Hwang 57 Chief Commercial Officer since October 2022 and President, Global Biopharmaceuticals Group since January 2019.
Group President, Pfizer Essential Health from January 2018 until December 2018.
2 unchanged sentences
Vaccines from January 2014 until December 2015.
−Removed: Vice President, Emerging Markets for the Primary Care therapeutic area from September 2011 until December 2013.
+Added: Vice President, Emerging Markets for Primary Care from September 2011 until December 2013.
Director of United Parcel Service, Inc.
13 unchanged sentences
Vice President of the Biotechnology Unit from 2012 until 2014.
+Added: William Pao 56 Chief Development Officer, Executive Vice President since March 2022.
+Added: Head of Roche Pharma Research & Early Development (pRED) and member of Roche’s Enlarged Corporate Executive Committee from 2018 until March 2022;
+Added: Senior Vice President, Global Head Oncology Discovery and Translational Area at Roche pRED from 2014 until 2018.
+Added: Vanderbilt University Medical Center Adjunct Professor from 2014 to present.
Payal Sahni 48 Chief People Experience Officer, Executive Vice President since January 2022.
6 unchanged sentences
Senior Vice President, Policy, External Affairs and Communications from December 2009 until December 2010.
−Removed: Director of WPP plc.
+Added: Director of WPP plc from 2013 to 2022.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.